Overview of Non Hodgkins Lymphoma
Newsletter Signup | Join Community | Cancer Types
Single dose of Pfizer vaccine doesn't protect cancer patients from COVID- Ask The Experts About COVID-19 and Lymphoma
Ukoniq PI3K inhibitor gets FDA approval for the management of Marginal Zone and Follicular Lymphoma
FDA approves Xalkori for treatment of ALK positive Anaplastic Large Cell Lymphoma
Lymphoma is a curable cancer and this continues to improve with newer precision medicines and immuntherapy
ASH 2020 Update - Bispecific antibody immunotherapy effective in refractory NHL - New option for elderly patients?
Parsaclisib is a PI3Kδ inhibitor precision medicine being developed in refractory B-cell lymphomas - ASH 2020 update.
Monjuvi precision medicine is effective in advanced lymphoma, evaluation moves to front line therapy.
How long have people been on watch and wait before they needed treatment ?
Rituxan Maintenance; has your doctor recommended it every 2 or every 3 months?
Long-Term Follow-Up Indicates Survival with Addition of Rituxan® to CHOP in NHL
Curious is others with celiac disease have develeoped lymphoma? https://mavendoctors…